{"DataElement":{"publicId":"2912001","version":"2","preferredName":"Congenital Abnormalities of Erythrocyte Differentiation or Function Classification Anemia Hemoglobinopathy Type","preferredDefinition":"A description of inherited abnormalities of erythrocyte differentiation or function classification.","longName":"2911997v1.0:2689128v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2911997","version":"1","preferredName":"Congenital Abnormalities of Erythrocyte Differentiation or Function Classification","preferredDefinition":"Inherited disorders involving abnormalities of red blood cell function, structure, or production.  Some diseases in this group may be associated with bone marrow failure, neutropenia, and/or thrombocytopenia._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"INH_AB_ERY_DIF_F_CLS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2934407","version":"1","preferredName":"Congenital Abnormalities of Erythrocyte Differentiation or Function","preferredDefinition":"Inherited disorders involving abnormalities of red blood cell function, structure, or production.  Some diseases in this group may be associated with bone marrow failure, neutropenia, and/or thrombocytopenia.","longName":"C61234","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Abnormalities of Erythrocyte Differentiation or Function","conceptCode":"C61234","definition":"Inherited disorders involving abnormalities of red blood cell function, structure, or production. Some diseases in this group may be associated with bone marrow failure, neutropenia, and/or thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71806156-0992-0D67-E040-BB89AD435F80","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D825F54-3B6B-678C-E040-BB89AD431C7F","latestVersionIndicator":"Yes","beginDate":"2009-06-29","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-06-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2689128","version":"1.1","preferredName":"Anemia Hemoglobinopathy Type","preferredDefinition":"A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability._A group of inherited disorders characterized by structural alterations within the hemoglobin molecule._Something distinguishable as an identifiable class based on common qualities.","longName":"ANM_HMGLBN_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Thalassemia, NOS","valueDescription":"Not Otherwise Specified Thalassemia","ValueMeaning":{"publicId":"2689129","version":"1","preferredName":"Not Otherwise Specified Thalassemia","longName":"2689129","preferredDefinition":"Not characterized in any other way.: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thalassemia","conceptCode":"C35069","definition":"An inherited blood disorder characterized by a decreased synthesis of one of the polypeptide chains that form hemoglobin. Anemia results from this abnormal hemoglobin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7D21-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-7283-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Fanconi anemia","valueDescription":"Fanconi anemia","ValueMeaning":{"publicId":"2579909","version":"1","preferredName":"Fanconi anemia","longName":"2579909","preferredDefinition":"A rare and often fatal inherited disease in which the bone marrow fails to produce red blood cells, white blood cells, platelets, or a combination of these cells. The disease may transform into myelodysplastic syndrome or leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fanconi Anemia","conceptCode":"C62505","definition":"An autosomal recessive genetic disorder characterized by bone marrow failure, skeletal abnormalities, and an increased incidence of the development of neoplasias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0532-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-7386-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Diamond-Blackfan anemia (pure red cell aplasia)","valueDescription":"Diamond-Blackfan Anemia PT: Congenital Pure Red Cell Aplasia","ValueMeaning":{"publicId":"3322760","version":"1","preferredName":"Diamond-Blackfan Anemia PT: Congenital Pure Red Cell Aplasia","longName":"3322760","preferredDefinition":"An inherited condition characterized by aplasia of the erythroid series only. The white cells and platelets are not affected. Patients develop anemia usually in infancy.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Pure Red Cell Aplasia","conceptCode":"C61236","definition":"An inherited condition characterized by aplasia of the erythroid series only. The white cells and platelets are not affected. Patients develop anemia usually in infancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3714D57-A77C-7A8F-E040-BB89AD43536C","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-737C-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Shwachman-Diamond","valueDescription":"Schwachmann-Diamond Syndrome","ValueMeaning":{"publicId":"3326330","version":"1","preferredName":"Schwachmann-Diamond Syndrome","longName":"3326330","preferredDefinition":"A rare, autosomal recessive disorder characterized by exocrine pancreas insufficiency, skeletal abnormalities, bone marrow dysfunction, and an increased incidence of leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shwachman-Diamond Syndrome","conceptCode":"C61235","definition":"A rare, autosomal recessive disorder characterized by exocrine pancreas insufficiency, skeletal abnormalities, bone marrow dysfunction, and an increased incidence of leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B61D-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-73A4-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Other hemoglobinopathy","valueDescription":"Other Hemoglobinopathy","ValueMeaning":{"publicId":"2689130","version":"1","preferredName":"Other Hemoglobinopathy","longName":"2689130","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7D91-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"KUMMEROA","dateModified":"2020-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72B5-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Other constitutional anemia","valueDescription":"Other Genetic Anemia","ValueMeaning":{"publicId":"2689229","version":"1","preferredName":"Other Genetic Anemia","longName":"2689229","preferredDefinition":"Not otherwise specified.: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells; inherited.: A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7DB6-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72BF-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Sickle cell disease","valueDescription":"sickle cell disease","ValueMeaning":{"publicId":"2579911","version":"1","preferredName":"sickle cell disease","longName":"2579911","preferredDefinition":"A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0534-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-73AE-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Sickle thalassemia","valueDescription":"Sickle Cell-Thalassemia","ValueMeaning":{"publicId":"3326333","version":"1","preferredName":"Sickle Cell-Thalassemia","longName":"3326333","preferredDefinition":"Hemolytic anemia, in which patients are heterozygous for both the sickle cell gene and a thalassemia gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell-Thalassemia","conceptCode":"C61237","definition":"Hemolytic anemia, in which patients are heterozygous for both the sickle cell gene and a thalassemia gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B688-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-73C2-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Acquired Severe Aplastic Anemia (SAA), NOS","valueDescription":"Severe Aplastic Anemia Not Otherwise Specified","ValueMeaning":{"publicId":"2689231","version":"1","preferredName":"Severe Aplastic Anemia Not Otherwise Specified","longName":"2689231v1.00","preferredDefinition":"Life-threatening anemia associated with a high risk of infection or bleeding._Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Aplastic Anemia","conceptCode":"C61229","definition":"Life-threatening anemia associated with a high risk of infection or bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7E29-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72DD-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Acquired SAA, secondary to toxin / other drug","valueDescription":"Drug-Induced Aplastic Anemia","ValueMeaning":{"publicId":"2593263","version":"1","preferredName":"Drug-Induced Aplastic Anemia","longName":"2593263","preferredDefinition":"A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug-Induced Aplastic Anemia","conceptCode":"C35343","definition":"A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CBB6-2204-0782-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"KUMMEROA","dateModified":"2020-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72E7-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Acquired SAA, secondary to hepatitis","valueDescription":"Aplastic Anemia due to Hepatitis","ValueMeaning":{"publicId":"2593261","version":"1","preferredName":"Aplastic Anemia due to Hepatitis","longName":"2593261","preferredDefinition":"Bone marrow failure defined as pancytopenia, secondary to hepatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia due to Hepatitis","conceptCode":"C61231","definition":"Bone marrow failure defined as pancytopenia, secondary to hepatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CB39-0225-077C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"KUMMEROA","dateModified":"2020-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72F1-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Acquired Pure Red Cell Aplasia (PRCA) (not congenital)","valueDescription":"acquired pure red cell aplasia","ValueMeaning":{"publicId":"2579829","version":"1","preferredName":"acquired pure red cell aplasia","longName":"2579829v1.00","preferredDefinition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children. Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Pure Red Cell Aplasia","conceptCode":"C70548","definition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children. Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04E2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-72FB-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Acquired amegakaryocytosis (not congenital)","valueDescription":"Not Genetic Amegakaryocytosis","ValueMeaning":{"publicId":"2689232","version":"1","preferredName":"Not Genetic Amegakaryocytosis","longName":"2689232v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amegakaryocytosis","conceptCode":"C61248","definition":"A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7E91-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-7305-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Other acquired cytopenic syndrome","valueDescription":"Other Not Genetic Cytopenia","ValueMeaning":{"publicId":"2689230","version":"1","preferredName":"Other Not Genetic Cytopenia","longName":"2689230","preferredDefinition":"Not otherwise specified.: An operation in which a term denies or inverts the meaning of another term or construction.: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells; inherited.: A reduction in the number of blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytopenia","conceptCode":"C2979","definition":"A laboratory test result indicating an abnormally low quantity of circulating blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7DE0-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-730F-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Beta thalassemia major","valueDescription":"Thalassemia Major","ValueMeaning":{"publicId":"3211478","version":"1","preferredName":"Thalassemia Major","longName":"3211478","preferredDefinition":"An autosomal recessive disorder that affects the production of beta polypeptide chains which are necessary for the hemoglobin synthesis. Anemia and failure to thrive are characteristic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beta Thalassemia","conceptCode":"C34375","definition":"An autosomal recessive disorder that affects the production of beta polypeptide chains which are necessary for the hemoglobin synthesis. Anemia and failure to thrive are characteristic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-03D9-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-7319-89EB-E040-BB89AD436F63","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"},{"value":"Paroxysmal nocturnal hemoglobinuria (PNH)","valueDescription":"Paroxysmal Nocturnal Hemoglobinuria","ValueMeaning":{"publicId":"2593267","version":"1","preferredName":"Paroxysmal Nocturnal Hemoglobinuria","longName":"2593267","preferredDefinition":"A rare acquired hematologic disorder characterized by hemolytic anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis. The episodes of hemolysis tend to occur at night. It is caused by a somatic mutation in the glycosylphosphatidylinositol biosynthesis gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paroxysmal Nocturnal Hemoglobinuria","conceptCode":"C61233","definition":"A rare acquired hematologic disorder characterized by hemolytic anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis. The episodes of hemolysis tend to occur at night. It is caused by a somatic mutation in the glycosylphosphatidylinositol biosynthesis gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CCB0-13F1-07E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8442759-3B1A-D56A-E040-BB89AD430BB7","beginDate":"2007-10-12","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2689127","version":"1","preferredName":"Anemia Hemoglobinopathy Type","preferredDefinition":"A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004:A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.:Type; a subdivision of a particular kind of thing.","longName":"C2869:C3092:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD2F5-9AC9-39CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"ONEDATA","dateModified":"2007-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E97F8ACE-726D-89EB-E040-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":".4/30/14mn-corrected spelling of PVID 2593267 PNH - hemoglobinuria.","administrativeNotes":"2023.8.9 Updated PV defs for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964924","version":"1","longName":"2400r1: Pre-TED","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_prime_dis_hct_inherit_ab_erythro_dif_class","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"pre_ted_who_hemglb_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_ICT_inhr_ab_eryth_dif_cls","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_IAED_inh_ab_ery_diff_clss","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the classification o","type":"Preferred Question Text","description":"What was the classification of the congenital abnormalities of erythrocyte differentiation or function?","url":null,"context":"NHLBI"},{"name":"Classification:","type":"Alternate Question Text","description":"Classification:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2912001","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.value(ANY=>CD).code","url":null,"context":"NHLBI"},{"name":"Specify the inherited abnormalities of erythrocyte differentiation or function classification","type":"Application Standard Question Text","description":"Specify the inherited abnormalities of erythrocyte differentiation or function classification","url":null,"context":"NHLBI"},{"name":"Specify the inherited abnormalities of erythrocyte differentiation or function classification","type":"Alternate Question Text","description":"Specify the inherited abnormalities of erythrocyte differentiation or function classification","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E97F8ACE-7492-89EB-E040-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2013-10-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".4/30/14mn-refreshed after update to vd. Added human readable def. System generated def displayed as alt def. No version needed. AK 11/17/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}